Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure freedomNew X-TOLE OLE data analysis supports the ability to ...
Xenon Pharmaceuticals (XENE) announced new data highlighting its commitment in epilepsy, including interim 48-month data from its ongoing X-TOLE ...
A team of researchers has announced their observation and measurement of the decay of Xenon-124, the rarest ever recorded. It ...
Scientists are using anesthesia to probe the quantum roots of consciousness—and the research offers tantalizing evidence.
A month has gone by since the last earnings report for Xenon Pharmaceuticals (XENE). Shares have added about 9.7% in that ...
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for ...
An international team of researchers have found a better way to separate two rare and important gases—xenon and krypton—that ...
Following extensive validation by Philips, the XENOVIEW® 3T Chest Coil is now confirmed for integration with Philips MRI systems starting in early 2026, including 3.0T platforms such as the MR 7700 ...
Abstract: This article describes a 3-kW simmer and 30-kV dc trigger power supply system for driving xenon flash lamps in large-area processes. Simmer power supply is designed to output maximum of 3 kV ...
Scientists found Chernobyl fuel grains that still contain radioactive gases and operational secrets from the reactor after 30 years ...
Advancing Photovoltaic Research with Plasma FIB: Insights from the Materials Characterization Centre
Discover how plasma FIB enables low-damage, large-area analysis for photovoltaics and CL in this expert interview with Dr.
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results